Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (12)

1

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma : long-term efficacy and safety from the phase II LOTIS-2 study

enthalten in: Haematologica | 2024

von Caimi, P. | Ai, W. | Alderuccio, J. | +13

2

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma : A phase 1/2 study

enthalten in: Cancer medicine | 2023

von Lesokhin, A. | LeBlanc, R. | Dimopoulos, M. | +18

3

A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma

enthalten in: Hematological oncology | 2023

von Carlo-Stella, C. | Zinzani, P. | Sureda, A. | +22

4

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

enthalten in: The New England journal of medicine | 2022

von Dickinson, M. | Carlo-Stella, C. | Morschhauser, F. | +18

CommentIn: N Engl J Med. 2022 Dec 15;387(24):2285-2286. - PMID 36507659

5

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma : results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

6

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2) : a multicentre, open-label, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2021

von Caimi, P. | Ai, W. | Alderuccio, J. | +15

CommentIn: Lancet Oncol. 2021 Jun;22(6):741-742. - PMID 33989556

7

Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas

enthalten in: Transplantation and cellular therapy | 2021

von Castagna, L. | Dodero, A. | Patriarca, F. | +13

8

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma : Final Results of a Multicenter Phase II Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Santoro, A. | Mazza, R. | Pulsoni, A. | +15

9

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Guidetti, A. | Carlo-Stella, C. | Locatelli, S. | +13

10

Phase II study of sorafenib in patients with relapsed or refractory lymphoma

enthalten in: British journal of haematology | 2012

von Guidetti, A. | Carlo-Stella, C. | Locatelli, S. | +15